Compare NVAX & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | AFYA |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1995 | 2019 |
| Metric | NVAX | AFYA |
|---|---|---|
| Price | $8.30 | $14.87 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $10.78 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 6.4M | 136.2K |
| Earning Date | 02-26-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | N/A | ★ 25.39 |
| EPS | ★ 2.07 | 1.50 |
| Revenue | ★ $1,064,651,000.00 | $681,742,784.00 |
| Revenue This Year | $58.91 | $14.73 |
| Revenue Next Year | N/A | $7.73 |
| P/E Ratio | ★ $4.20 | $10.21 |
| Revenue Growth | ★ 20.27 | 14.07 |
| 52 Week Low | $5.01 | $13.12 |
| 52 Week High | $10.65 | $19.90 |
| Indicator | NVAX | AFYA |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 51.75 |
| Support Level | $9.16 | $13.34 |
| Resistance Level | $10.20 | $15.46 |
| Average True Range (ATR) | 0.69 | 0.48 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 22.67 | 74.79 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.